Analyzing...
Loading company...
No significant concerns identified
Nothing flagged for monitoring
“Services business in Commercial & Professional Services.”
₹727 Cr service revenue.
Employee costs at 45.1% of revenue — primary cost driver.
“MPS is comfortably placed to surpass an EPS of 100 rupees in f y twenty six.”
“Revenue grew by 11.”
“expecting to cross 100 rupees this”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 35.4%▲ | 4.8% |
| ROCE | 42.7%▲ | 6.0% |
| Net Margin | 22.7%▲ | 3.9% |
| EBITDA Margin | 33.2%▲ | 9.0% |
| Debt To Equity | 0.00x▼ | 0.10x |
| Rev Growth 3yr | 16.9%▲ | 9.2% |
| EPS Growth 3yr | 19.6%▲ | 0.8% |
| Employee Cost Ratio | 45.10x | - |
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹745 Cr +2.5% | ₹727 Cr +33.3% | ₹545 Cr +8.8% | ₹501 Cr +11.6% | ₹449 Cr +6.2% | ₹423 Cr +27.4% | ₹332 Cr -8.5% | ₹363 Cr |
| Other Income | ₹19 Cr +48.7% | ₹13 Cr +2.5% | ₹12 Cr +13.4% | ₹11 Cr -23.6% | ₹14 Cr +42.8% | ₹10 Cr -50.6% | ₹20 Cr -20.9% | ₹25 Cr |
| Total Income | ₹764 Cr +3.3% | ₹739 Cr +32.6% | ₹558 Cr +8.9% | ₹512 Cr +10.6% | ₹463 Cr +7.1% | ₹432 Cr +23.0% | ₹352 Cr -9.3% | ₹388 Cr |
| ₹548 Cr +0.8% | ₹544 Cr +37.3% | ₹396 Cr +8.6% | ₹365 Cr +5.8% | ₹345 Cr +1.8% | ₹339 Cr +25.5% | ₹270 Cr -3.7% | ₹280 Cr | |
| Profit Before Tax | ₹226 Cr +12.5% | ₹201 Cr +24.7% | ₹161 Cr +9.8% | ₹147 Cr +24.6% | ₹118 Cr +26.3% | ₹93 Cr +14.7% | ₹81 Cr -24.2% | ₹107 Cr |
| Exceptional Items | ₹11 Cr +81.2% | ₹6 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
| ₹53 Cr +1.6% | ₹52 Cr +22.9% | ₹42 Cr +12.6% | ₹38 Cr +22.4% | ₹31 Cr -11.5% | ₹35 Cr +61.5% | ₹22 Cr -31.2% | ₹31 Cr | |
| Net Profit | ₹173 Cr +16.3% | ₹149 Cr +25.4% | ₹119 Cr +8.8% | ₹109 Cr +25.3% | ₹87 Cr +48.8% | ₹59 Cr -2.2% | ₹60 Cr -21.3% | ₹76 Cr |
| Profit (Owners) | ₹173 Cr +16.3% | ₹149 Cr +25.4% | ₹119 Cr +8.8% | ₹109 Cr +25.3% | ₹87 Cr +48.8% | ₹59 Cr -2.2% | ₹60 Cr -21.3% | ₹76 Cr |
| Other Comprehensive Income | ₹8 Cr +119.5% | ₹4 Cr +64.4% | ₹2 Cr -81.1% | ₹12 Cr +179.3% | ₹4 Cr ↑ Recovery | (₹2 Cr) ↓ Decline | ₹6 Cr +91.4% | ₹3 Cr |
| EPS | ₹101.28 | ₹87.05 | ₹69.43 | ₹63.83 | ₹50.93 | ₹32.44 | ₹32.15 | ₹40.84 |
| Diluted Shares | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
MPS Limited has informed the Exchange about Investor Presentation
MPS Limited has informed the Exchange regarding Change in Auditors of the company.
MPS Limited has informed the Exchange regarding Change in Auditors of the company.
MPS Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
MPS Limited has informed the Exchange regarding Resignation of Mr Sreenivas Trichy Venkatraman as Other of the company w.e.f. August 03, 2026.
MPS Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
MPS Limited has informed the Exchange about Update on Mode of Participation in the Conference Call on Acquisition of Unbound Medicine, Inc., USA. There is no change in the date, time, subject matter o...
MPS Limited has informed the Exchange about a conference call on Wednesday, 18 February 2026, on the acquisition of Unbound Medicine Inc., USA.
Completion of the acquisition of Unbound Medicine, Inc., USA, by MPS North America LLC, a wholly owned subsidiary of the Company.
MPS Limited has submitted the Exchange a copy of the Scrutinizer Report of the Postal Ballot process through remote e-voting initiated by the Company in terms of Notice of Postal Ballot dated 24 Decem...
MPS Limited has informed the Exchange regarding the voting results of the Postal Ballot process through remote e-voting initiated by the Company in terms of the Notice of Postal Ballot dated 24 Decemb...
MPS Limited has informed the Exchange about Transcript
MPS Limited has informed the Exchange about Funding arrangements for the proposed acquisition of Unbound Medicine, Inc., by MPS North America LLC, a wholly-owned subsidiary of MPS Limited.
Submission of Newspaper Publication of Un-Audited Financial Results for the Third Quarter (Q3) & Nine Months ended 31 December 2025
Audio Recording for the Earnings Conference Call inter-alia on Un-Audited Financial Results of MPS Limited for the Third Quarter (Q3) & Nine Months ended 31 December 2025.